finasteride

Poland

Drugs containing this active substance

  • ADASTER

    The medicine is intended exclusively for men with mild enlargement of the prostate gland. It helps to reduce the enlarged prostate, alleviates urinary symptoms, and reduces the risk of sudden urinary retention and the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Adamed Pharma S.A. APL Swift Services (Malta) Ltd.

  • The medicine is intended for the treatment of male pattern hair loss in men. It helps increase hair growth and prevents further hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 1 mg

    ATC: D11AX10

    Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

  • The medicine is used for the treatment and control of mild enlargement of the prostate gland. It helps to reduce its size, improves urine flow, relieves symptoms, and reduces the risk of acute urinary retention or the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Haupt Pharma Muenster GmbH, Siegfried Malta Ltd.

  • It is used for the treatment and control of mild enlargement of the prostate gland in men. It helps to reduce its volume, improves urine flow, relieves symptoms, and reduces the risk of acute urinary retention or the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Orion Corporation

  • The medicine is used for the treatment and control of benign prostatic hyperplasia (enlarged prostate). It helps to reduce its size, improve urine flow, relieve symptoms, and reduce the risk of acute urinary retention or the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Actavis Group PTC ehf. Zentiva, joint-stock company

  • It is used in the treatment of mild benign prostatic hyperplasia (BPH) in men.

    Form: tablets, film-coated

    Active substance Dosage
    doxazosin 4 mg
    finasteride 5 mg

    ATC: G04CA55

    Manufacturer: MIP Pharma GmbH

  • The medicine is used for the treatment and prevention of mild enlargement of the prostate gland in men. It helps to reduce the size of the enlarged gland, improves urine flow, and relieves symptoms associated with this condition.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Accord Healthcare B.V.

  • It is used in men to treat male-pattern (androgenetic) alopecia and to prevent further hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 1 mg

    ATC: D11AX10

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o. Laboratorios Normon, S.A.

  • The medicine is used for the treatment and control of prostate enlargement (benign prostatic hyperplasia). It helps to reduce the size of the prostate, improves urine flow, relieves associated symptoms, and reduces the risk of acute urinary retention and the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Pharmachemie B.V. Teva Operations Polska Sp. z o.o. Teva Pharmaceutical Works Private Limited Company

  • The medicine is intended for men with male-pattern hair loss (androgenetic alopecia). It helps increase hair growth and prevents further hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 1 mg

    ATC: D11AX10

    Manufacturer: mibe GmbH Pharmaceuticals

  • It is used in men to treat mild enlargement of the prostate gland. It helps relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Haupt Pharma Muen游戏副本 GmbH Siegfried Barbera, S.L.

  • The medicine is used in men to treat and control benign prostatic hyperplasia. It helps to reduce the size of the enlarged prostate, improve urine flow, relieve associated symptoms, and reduce the risk of needing surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: LEK S.A. Salutas Pharma GmbH

  • The medicine is used in men to treat benign prostatic hyperplasia. It helps relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

  • The medicine is used for the treatment and control of benign prostatic hyperplasia (BPH) in men. It helps to reduce the size of the prostate, improves urine flow, relieves symptoms, and reduces the risk of acute urinary retention or the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Bluefish Pharmaceuticals AB Pharmadox Healthcare Ltd.

  • The medicine is used to reduce an enlarged prostate (benign prostatic hyperplasia) in men, which helps to relieve urinary problems.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Dr. Max Pharma s.r.o. Medis International a.s.

  • The medicine is used in the treatment of benign prostatic hyperplasia (BPH) in men. It helps to reduce the enlarged prostate, which can improve urination and reduce the risk of sudden inability to urinate and the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Tecnimede-Sociedade Técnico-Medicinal S.A.

  • The medicine is used for the treatment and control of benign prostatic enlargement (benign prostatic hyperplasia – BPH).

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Eurogenerics NV/SA Haupt Pharma Muenster GmbH PharmaCoDane ApS, Siegfried Generis Malta Ltd STADA Arzneimittel AG Stada Arzneimittel GesmbH

  • The medicine is used in men aged 18 to 41 years to treat mild to moderate male pattern hair loss. It helps increase hair growth on the scalp and prevents further hair loss.

    Form: spray, topical solution

    Active substance Dosage
    finasteride 2.275 mg/ml

    ATC: D11AX10

    Manufacturer: Almirall Hermal GmbH

  • The medicine is used to treat and inhibit the progression of mild (non-cancerous) enlargement of the prostate gland in men.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Actavis ehf. Krka, d.d., Novo mesto

  • It is used in the treatment of mild enlargement of the prostate gland in men. It helps to relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Haupt Pharma Muenster GmbH, Siegfried Barberá, S.L.

  • The medicine is used for the treatment and control of benign prostatic hyperplasia in men.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Actavis Group PTC ehf. G.L. Pharma GmbH Genericon Pharma GmbH

  • The medicine is intended exclusively for men aged 18 to 41 with mild to moderate hair loss (male pattern alopecia). It helps slow the progression of hair loss and promotes hair regrowth in many men.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 1 mg

    ATC: D11AX10

    Manufacturer: Aristo Pharma GmbH Pharmadox Healthcare Ltd.

  • The medicine is used in men to treat mild enlargement of the prostate gland. It helps to relieve symptoms, reduce the enlarged gland, improve urine flow, and reduce the risk of acute urinary retention or the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Zentiva, joint-stock company

  • The medicine is used in men to treat male-pattern (androgenetic) alopecia. It helps increase hair growth and prevents further hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 1 mg

    ATC: D11AX10

    Manufacturer: Merck Sharp & Dohme B.V. Organon Heist bv

  • It is used in men to treat benign prostatic hyperplasia. It helps relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Merck Sharp & Dohme B.V. Organon Heist bv

  • The medicine is used in men to treat mild enlargement of the prostate gland. It helps relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Farmak International Limited Liability Company

  • The medicine is used for the treatment and control of benign prostatic hyperplasia (BPH). It helps to reduce symptoms such as frequent urination (especially at night), urgency, difficulty starting urination, or a weak urinary stream. It also reduces the risk of acute urinary retention and the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Heumann Pharma GmbH Pharmadox Healthcare Ltd.

  • It is used in the treatment of mild enlargement of the prostate gland in men. It helps to relieve symptoms, reduces the risk of acute urinary retention, and reduces the risk of the need for surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride 5 mg

    ATC: G04CB01

    Manufacturer: Gedeon Richter Plc.